CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017
September 08, 2017 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Sept. 08, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to...
CohBar, Inc. Announces Second Quarter 2017 Financial Results
August 14, 2017 16:05 ET
|
CohBar, Inc.
MENLO PARK, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company focused on developing mitochondria based...
CohBar, Inc. to Announce Second Quarter 2017 Financial Results and Host Conference Call for Shareholders on August 14, 2017
July 27, 2017 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSX-V:COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs)...
CohBar, Inc. Completes US$5.2 Million Private Placement
July 17, 2017 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company focused on developing mitochondria...
CohBar, Inc. Announces Private Placement Offering
June 23, 2017 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., June 23, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company focused on developing mitochondria...
CohBar, Inc. to Hold 2017 Annual Shareholder Meeting and Investor Update June 15, 2017
June 01, 2017 16:15 ET
|
CohBar, Inc.
MENLO PARK, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSX-V:COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs)...
CohBar, Inc. Announces First Quarter 2017 Financial Results
May 15, 2017 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSX-V:COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs)...